A Practical Synthesis of YZD-7082B, a Novel Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of ER+ Breast Cancer.
Molecular diversity（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined